Name | Title | Contact Details |
---|---|---|
Katie Bevier |
Chief Technology Officer | Profile |
Aunt Millie’s is a family-owned bread company based in Fort Wayne, Indiana and operating five bakeries across three states in the Midwest. We specialize in breads, buns, and rolls. One taste and you’ll agree, we don’t just bake bread—we bake m...
Delivering delicious prepared meals that adhere to Paleo, gluten-free, dairy-free, anti-inflammatory and organic diets throughout Chicago and suburbs.
Get heathy, easy & ready to eat food delivered to your door. 100% plant-based vegan & gluten free. The only zero waste meal delivery service!
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.